Beta-thalassemia major and female fertility: The role of iron and iron-induced oxidative stress

Anemia

Volumn 2013, Issue , 2013, Pages

  Roussou, Paraskevi ^a   Tsagarakis, Nikolaos J ^a   Kountouras, Dimitrios ^a   Livadas, Sarantis ^a   Diamanti Kandarakis, Evanthia ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893743248     PISSN: 20901267     EISSN: 20901275     Source Type: Journal    
DOI: 10.1155/2013/617204     Document Type: Article

References (82)

1. Hershko C., Pathogenesis and management of iron toxicity in thalassemia. Annals of the New York Academy of Sciences 2010 1202 1 9 2-s2.0-77955915545 10.1111/j.1749-6632.2010.05544.x
2. Waseem F., Khemomal K. A., Sajid R., Antioxidant status in beta thalassemia major: a single-center study. Indian Journal of Pathology and Microbiology 2011 54 4 761 763 2-s2.0-84856365960 10.4103/0377-4929.91489
3. Origa R., Piga A., Quarta G., Forni G. L., Longo F., Melpignano A., Galanello R., Pregnancy and β -thalassemia: an Italian multicenter experience. Haematologica 2010 95 3 376 381 2-s2.0-77949716941 10.3324/haematol.2009.012393
4. Skordis N., Petrikkos L., Toumba M., Simamonian K., Hadjigavriel M., Sitarou M., Kolnakou A., Skordos G., Pangalou E., Christou S., Update on fertility in thalassaemia major. Pediatric Endocrinology Reviews 2004 2 supplement 2 296 302 2-s2.0-19944432283
5. Toumba M., Sergis A., Kanaris C., Skordis N., Endocrine complications in patients with thalassaemia major. Pediatric Endocrinology Reviews 2007 5 2 642 648 2-s2.0-37549022198
6. Rachmilewitz E. A., Weizer-Stern O., Adamsky K., Amariglio N., Rechavi G., Breda L., Rivella S., Cabantchik Z. I., Role of iron in inducing oxidative stress in thalassemia: can it be prevented by inhibition of absorption and by antioxidants? Annals of the New York Academy of Sciences 2005 1054 118 123 2-s2.0-29744461403 10.1196/annals.1345.014 (Pubitemid 43031016)
7. Ansari S., Azarkeivan A., Tabaroki A., Pregnancy in patients treated for beta thalassemia major in two centers (Ali Asghar Children's Hospital and Thalassemia Clinic): outcome for mothers and newborn infants. Pediatric Hematology-Oncology 2006 23 1 33 37 2-s2.0-28844490563 10.1080/08880010500313306 (Pubitemid 41769971)
8. Safarinejad M. R., Reproductive hormones and hypothalamic-pituitary- ovarian axis in female patients with homozygous β -thalassemia major. Journal of Pediatric Hematology/Oncology 2010 32 4 259 266 2-s2.0-77952775767 10.1097/MPH.0b013e3181cf8156
9. Singer S. T., Vichinsky E. P., Gildengorin G., van Disseldorp J., Rosen M., Cedars M. I., Reproductive capacity in iron overloaded women with thalassemia major. Blood 2011 118 10 2878 2881 2-s2.0-80052685808 10.1182/blood-2011-06-360271
10. Vizziello G., Carone D., Caroppo E., Vitti A., Pasquadibisceglie A., D'amato G., Ovulation induction with gonadotropin in patients with thalassemia pretreated with pulsatile GnRH: outcome. Minerva Ginecologica 2004 56 5 485 487 2-s2.0-11144299594 (Pubitemid 40039224)
11. Skordis N., Christou S., Koliou M., Pavlides N., Angastiniotis M., Fertility in female patients with thalassemia. Journal of Pediatric Endocrinology and Metabolism 1998 11 supplement 3 935 943 2-s2.0-0032411408
12. Danesi L., Scacchi M., Miragoli A. M., Pincelli A. I., Bubini A., Maiolo A., Cavagnini F., Polli E. E., Induction of follicle maturation and ovulation by gonadotropin administration in women with β -thalassemia. European Journal of Endocrinology 1994 131 6 602 606 2-s2.0-0028113436 (Pubitemid 24377191)
13. Bajoria R., Chatterjee R., Current perspectives of fertility and pregnancy in thalassemia. Hemoglobin 2009 33 supplement 1 S131 S135 2-s2.0-73949160586 10.3109/03630260903365023
14. Bajoria R., Chatterjee R., Hypogonadotrophic hypogonadism and diminished gonadal reserve accounts for dysfunctional gametogenesis in thalassaemia patients with iron overload presenting with infertility. Hemoglobin 2011 35 5-6 636 642 2-s2.0-81055144337 10.3109/03630269.2011.623809
15. Karagiorga-Lagana M., Fertility in thalassemia: the Greek experience. Journal of Pediatric Endocrinology and Metabolism 1998 11 supplement 3 945 951 2-s2.0-0032437614
16. Tuck S. M., Fertility and pregnancy in thalassemia major. Annals of the New York Academy of Sciences 2005 1054 300 307 2-s2.0-29744465830 10.1196/annals.1345.062 (Pubitemid 43031037)
17. Surbek D., Koller A., Pavic N., Successful twin pregnancy in homozygous β -thalassemia after ovulation induction with growth hormone and gonadotropins. Fertility and Sterility 1996 65 3 670 672 2-s2.0-0030024014 (Pubitemid 26069131)
18. Yamaguchi K., Mandai M., Toyokuni S., Hamanishi J., Higuchi T., Takakura K., Fujii S., Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress. Clinical Cancer Research 2008 14 1 32 40 2-s2.0-40749162395 10.1158/1078-0432.CCR-07-1614 (Pubitemid 351377975)
19. Kew M. C., Hepatic iron overload and hepatocellular carcinoma. Cancer Letters 2009 286 1 38 43 2-s2.0-70350567326 10.1016/j.canlet.2008.11.001
20. Agarwal A., Gupta S., Sharma R. K., Role of oxidative stress in female reproduction. Reproductive Biology and Endocrinology 2005 3, article 28 2-s2.0-27344456070 10.1186/1477-7827-3-28 (Pubitemid 41522097)
21. Chan A. C., Chow C. K., Chiu D., Interaction of antioxidants and their implication in genetic anemia. Proceedings of the Society for Experimental Biology and Medicine 1999 222 3 274 282 2-s2.0-0032726828 (Pubitemid 129708642)
22. Agarwal A., Aponte-Mellado A., Premkumar B. J., Shaman A., Gupta S., The effects of oxidative stress on female reproduction: a review. Reproductive Biology and Endocrinology 2012 10, article 49 10.1186/1477-7827-10-49
23. Giergiel M., Lopucki M., Stachowicz N., Kankofer M., The influence of age and gender on antioxidant enzyme activities in humans and laboratory animals. Aging Clinical and Experimental Research 2012 24 551 559
24. Shazia Q., Mohammad Z. H., Rahman T., Shekhar H. U., Correlation of oxidative stress with serum trace element levels and antioxidant enzyme status in Beta thalassemia major patients: a review of the literature. Anemia 2012 2012 7 270923 10.1155/2012/270923
25. Abdalla M. Y., Fawzi M., Al-Maloul S. R., El-Banna N., Tayyem R. F., Ahmad I. M., Increased oxidative stress and iron overload in Jordanian β -thalassemic children. Hemoglobin 2011 35 1 67 79 2-s2.0-79952169044 10.3109/03630269.2010.544624
26. Ghone R. A., Kumbar K. M., Suryakar A. N., Katkam R. V., Joshi N. G., Oxidative stress and disturbance in antioxidant balance in beta thalassemia major. Indian Journal of Clinical Biochemistry 2008 23 4 337 340 2-s2.0-57149119307 10.1007/s12291-008-0074-7
27. Livrea M. A., Tesoriere L., Pintaudi A. M., Calabrese A., Maggio A., Freisleben H.-J., D'Arpa D., D'Anna R., Bongiorno A., Oxidative stress and antioxidant status in β -thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 1996 88 9 3608 3614 2-s2.0-0029959755 (Pubitemid 26365599)
28. Chiou S.-S., Chang T.-T., Tsai S.-P., Jang R.-C., Lin S.-K., Lee S.-C., Tsai S.-M., Tsai L.-Y., Lipid peroxidation and antioxidative status in β -thalassemia major patients with or without hepatitis C virus infection. Clinical Chemistry and Laboratory Medicine 2006 44 10 1226 1233 2-s2.0-33750034922 10.1515/CCLM.2006.219 (Pubitemid 44580805)
29. Agarwal A., Allamaneni S. S., Role of free radicals in female reproductive diseases and assisted reproduction. Reproductive BioMedicine Online 2004 9 3 338 347 2-s2.0-4544300285 (Pubitemid 39214174)
30. Ruder E. H., Hartman T. J., Blumberg J., Goldman M. B., Oxidative stress and antioxidants: exposure and impact on female fertility. Human Reproduction Update 2008 14 4 345 357 2-s2.0-45549098881 10.1093/humupd/dmn011 (Pubitemid 351858974)
31. Agarwal A., Gupta S., Sekhon L., Shah R., Redox considerations in female reproductive function and assisted reproduction: from molecular mechanisms to health implications. Antioxidants & Redox Signaling 2008 10 8 1375 1403 2-s2.0-51749088818 10.1089/ars.2007.1964
32. Devine P. J., Perreault S. D., Luderer U., Roles of reactive oxygen species and antioxidants in ovarian toxicity. Biology of Reproduction 2012 86 2, article 27 2-s2.0-84860231131 10.1095/biolreprod.111.095224
33. Al-Gubory K. H., Garrel C., Faure P., Sugino N., Roles of antioxidant enzymes in corpus luteum rescue from reactive oxygen species-induced oxidative stress. Reproductive Biomedicine Online 2012 25 6 551 560 10.1016/j.rbmo.2012. 08.004
34. Agarwal A., Aponte-Mellado A., Premkumar B. J., Shaman A., Gupta S., The effects of oxidative stress on female reproduction: a review. Reproductive Biology and Endocrinology 2012 10, article 49 10.1186/1477-7827-10-49
35. Defrere S., Gonzalez-Ramos R., Lousse J.-C., Colette S., Donnez O., Donnez J., Van Langendonckt A., Insights into iron and nuclear factor-kappa B (NF- B) involvement in chronic inflammatory processes in peritoneal endometriosis. Histology and Histopathology 2011 26 8 1083 1092 2-s2.0-80053201966
36. van Langendonckt A., Casanas-Roux F., Donnez J., Oxidative stress and peritoneal endometriosis. Fertility and Sterility 2002 77 5 861 870 2-s2.0-0036247944 10.1016/S0015-0282(02)02959-X (Pubitemid 34497149)
37. Appasamy M., Jauniaux E., Serhal P., Al-Qahtani A., Groome N. P., Muttukrishna S., Evaluation of the relationship between follicular fluid oxidative stress, ovarian hormones, and response to gonadotropin stimulation. Fertility and Sterility 2008 89 4 912 921 2-s2.0-41749099496 10.1016/j.fertnstert.2007.04.034 (Pubitemid 351491226)
38. Asano Y., Age-related accumulation of non-heme ferric and ferrous iron in mouse ovarian stroma visualized by sensitive non-heme iron histochemistry. The Journal of Histochemistry & Cytochemistry 2012 60 3 229 242 2-s2.0-84859644200 10.1369/0022155411431734
39. Al-Azemi M. K., Omu A. E., Fatinikun T., Mannazhath N., Abraham S., Factors contributing to gender differences in serum retinol and α -tocopherol in infertile couples. Reproductive BioMedicine Online 2009 19 4 583 590 2-s2.0-70449102776 10.1016/j.rbmo.2009.05.005
40. Kim M. K., Lee J. W., Baek K. H., Endocrinopathies in transfusion-associated iron overload. Clinical Endocrinology 2013 78 2 271 277 10.1111/j.1365-2265.2012.04495.x
41. Hempenius L. M., van Dam P. S., Marx J. J., Koppeschaar H. P., Mineralocorticoid status and endocrine dysfunction in severe hemochromatosis. Journal of Endocrinological Investigation 1999 22 5 369 376 2-s2.0-0033067127 (Pubitemid 29259559)
42. Vasquez J. M., Greenblatt R. B., Pituitary responsiveness to luteinizing-hormone-releasing hormone in different reproductive disorders. a review. Journal of Reproductive Medicine for the Obstetrician and Gynecologist 1985 30 8 591 600 2-s2.0-0022414015 (Pubitemid 16246417)
43. Paris I., Hermans M., Buysschaert M., Endocrine complications of genetic hemochromatosis. Acta Clinica Belgica 1999 54 6 334 345 2-s2.0-0033383337 (Pubitemid 30056200)
44. Stremmel W., Niederau C., Berger M., Kley H.-K., Kruskemper H.-L., Strohmeyer G., Abnormalities in estrogen, androgen, and insulin metabolism in idiopathic hemochromatosis. Annals of the New York Academy of Sciences 1988 526 209 223 2-s2.0-0023769672
45. Meyer W. R., Hutchinson-Williams K. A., Jones E. E., Decherney A. H., Secondary hypogonadism in hemochromatosis. Fertility and Sterility 1990 54 4 740 742 2-s2.0-0025011328 (Pubitemid 20350672)
46. Siemons L. J., Mahler C. H., Hypogonadotropic hypogonadism in hemochromatosis: recovery of reproductive function after iron depletion. The Journal of Clinical Endocrinology and Metabolism 1987 65 3 585 587 2-s2.0-0023194463 (Pubitemid 17135177)
47. McDermott J. H., Walsh C. H., Hypogonadism in hereditary hemochromatosis. The Journal of Clinical Endocrinology and Metabolism 2005 90 4 2451 2455 2-s2.0-17844410928 10.1210/jc.2004-0980 (Pubitemid 40586299)
48. Kontogeorgos G., Handy S., Kovacs K., Horvath E., Scheithauer B. W., The anterior pituitary in hemochromatosis. Endocrine Pathology 1996 7 2 159 164 2-s2.0-0141749496 (Pubitemid 126715146)
49. Piperno A., Rivolta M. R., D'alba R., Fargion S., Rovelli F., Ghezzi A., Micheli M., Fiorelli G., Preclinical hypogonadism in genetic hemochromatosis in the early stage of the disease: evidence of hypothalamic dysfunction. Journal of Endocrinological Investigation 1992 15 6 423 428 2-s2.0-0026739378
50. Siminoski K., D'costa M., Walfish P. G., Hypogonadotropic hypogonadism in idiopathic hemochromatosis: evidence for combined hypothalamic and pituitary involvement. Journal of Endocrinological Investigation 1990 13 10 849 853 2-s2.0-0025606346
51. Oerter K. E., Kamp G. A., Munson P. J., Nienhuis A. W., Cassorla F. G., Manasco P. K., Multiple hormone deficiencies in children with hemochromatosis. The Journal of Clinical Endocrinology and Metabolism 1993 76 2 357 361 2-s2.0-0027457937 10.1210/jc.76.2.357 (Pubitemid 23073055)
52. Noetzli L. J., Panigrahy A., Mittelman S. D., Hyderi A., Dongelyan A., Coates T. D., Wood J. C., Pituitary iron and volume predict hypogonadism in transfusional iron overload. American Journal of Hematology 2012 87 2 167 171 2-s2.0-84855960714 10.1002/ajh.22247
53. Chatterjee R., Katz M., Reversible hypogonadotrophic hypogonadism in sexually infantile male thalassaemic patients with transfusional iron overload. Clinical Endocrinology 2000 53 1 33 42 2-s2.0-0033846355 10.1046/j.1365-2265. 2000.00962.x (Pubitemid 30646124)
54. Berkovitch M., Bistritzer T., Milone S. D., Perlman K., Kucharczyk W., Olivieri N. F., Iron deposition in the anterior pituitary in homozygous beta-thalassemia: MRI evaluation and correlation with gonadal function. Journal of Pediatric Endocrinology & Metabolism 2000 13 2 179 184 (Pubitemid 30117213)
55. Arguelles S., Cano M., Machado A., Ayala A., Effect of aging and oxidative stress on elongation factor-2 in hypothalamus and hypophysis. Mechanisms of Ageing and Development 2011 132 1-2 55 64 2-s2.0-79251595904 10.1016/j.mad.2010.12.002
56. Gonzalez-Duarte D., Madrazo-Atutxa A., Soto-Moreno A., Leal-Cerro A., Measurement of oxidative stress and endothelial dysfunction in patients with hypopituitarism and severe deficiency adult growth hormone deficiency. Pituitary 2012 15 4 589 597 2-s2.0-84855386679 10.1007/s11102-011-0374-4
57. Birkenfeld A., Goldfarb A. W., Rachmilewitz E. A., Schenker J. G., Okon E., Endometrial glandular haemosiderosis in homozygous beta-thalassaemia. European Journal of Obstetrics Gynecology and Reproductive Biology 1989 31 2 173 178 2-s2.0-0024577774 (Pubitemid 19134241)
58. Singer S. T., Sweeters N., Vega O., Higa A., Vichinsky E., Cedars M., Fertility potential in thalassemia major women: current findings and future diagnostic tools. Annals of the New York Academy of Sciences 2010 1202 226 230 2-s2.0-77955876121 10.1111/j.1749-6632.2010.05583.x
59. Dissayabutra T., Tosukhowong P., Seksan P., The benefits of vitamin C and vitamin E in children with beta-thalassemia with high oxidative stress. Journal of the Medical Association of Thailand 2005 88 supplement 4 S317 321 2-s2.0-33646854927
60. Weeraphan C., Srisomsap C., Chokchaichamnankit D., Role of curcuminoids in ameliorating oxidative modification in beta-thalassemia/Hb E plasma proteome. The Journal of Nutritional Biochemistry 2012 24 3 578 585 10.1016/j.jnutbio. 2012.02.008
61. Vichinsky E., Emerging "A" therapies in hemoglobinopathies: agonists, antagonists, antioxidants, and arginine. Hematology American Society Hematology Education Program 2012 2012 1 271 275 10.1182/asheducation-2012.1.271
62. Mora-Esteves C., Shin D., Nutrient supplementation: improving male fertility fourfold. Seminars in Reproductive Medicine 2013 31 4 293 300 10.1055/s-0033-1345277
63. Kontoghiorghes G. J., Efstathiou A., Kleanthous M., Michaelides Y., Kolnagou A., Risk/benefit assessment, advantages over other drugs and targeting methods in the use of deferiprone as a pharmaceutical antioxidant in iron loading and non iron loading conditions. Hemoglobin 2009 33 5 386 397 2-s2.0-70350694439 10.3109/03630260903217141
64. Kuppusamy U. R., Tan J. A., Chelation therapy with desferrioxamine does not normalize ferritin level but attenuates oxidative damage and improves total antioxidant level in Malaysian Chinese beta-thalassaemia major patients. The West Indian Medical Journal 2011 60 1 3 8 2-s2.0-80155198934
65. Walter P. B., Macklin E. A., Porter J., Evans P., Kwiatkowski J. L., Neufeld E. J., Coates T., Giardina P. J., Vichinsky E., Olivieri N., Alberti D., Holland J., Harmatz P., Inflammation and oxidant-stress in β -thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial. Haematologica 2008 93 6 817 825 2-s2.0-44949113103 10.3324/haematol.11755 (Pubitemid 351821718)
66. Fenkci V., Fenkci S., Yilmazer M., Serteser M., Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertility and Sterility 2003 80 1 123 127 2-s2.0-0037707406 10.1016/S0015-0282(03)00571-5 (Pubitemid 36808867)
67. Tatone C., Carbone M. C., Falone S., Aimola P., Giardinelli A., Caserta D., Marci R., Pandolfi A., Ragnelli A. M., Amicarelli F., Age-dependent changes in the expression of superoxide dismutases and catalase are associated with ultrastructural modifications in human granulosa cells. Molecular Human Reproduction 2006 12 11 655 660 2-s2.0-33750218248 10.1093/molehr/gal080 (Pubitemid 44605597)
68. Gonzalez F., Rote N. S., Minium J., Kirwan J. P., Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism 2006 91 1 336 340 2-s2.0-30344440819 10.1210/jc.2005-1696 (Pubitemid 43069159)
69. Basta G., Lazzerini G., Massaro M., Simoncini T., Tanganelli P., Fu C., Kislinger T., Stern D. M., Schmidt A. M., De Caterina R., Advanced glycation end products activate endothelium through signal-transduction receptor RAGE a mechanism for amplification of inflammatory responses. Circulation 2002 105 7 816 822 2-s2.0-0037133280 10.1161/hc0702.104183 (Pubitemid 34174921)
70. Devangelio E., Santilli F., Formoso G., Ferroni P., Bucciarelli L., Michetti N., Clissa C., Ciabattoni G., Consoli A., Davì G., Soluble RAGE in type 2 diabetes: association with oxidative stress. Free Radical Biology and Medicine 2007 43 4 511 518 2-s2.0-34447331279 10.1016/j.freeradbiomed.2007.03. 015 (Pubitemid 47058227)
71. Basta G., Schmidt A. M., de Caterina R., Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovascular Research 2004 63 4 582 592 2-s2.0-4043058031 10.1016/j.cardiores.2004.05.001 (Pubitemid 39078671)
72. Meerwaldt R., Links T., Zeebregts C., Tio R., Hillebrands J.-L., Smit A., The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes. Cardiovascular Diabetology 2008 7, article 29 2-s2.0-54349093815 10.1186/1475-2840-7-29
73. Unoki H., Yamagishi S., Advanced glycation end products and insulin resistance. Current Pharmaceutical Design 2008 14 10 987 989 2-s2.0-44449114217 10.2174/138161208784139747 (Pubitemid 351753287)
74. Diamanti-Kandarakis E., Piperi C., Kalofoutis A., Creatsas G., Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome. Clinical Endocrinology 2005 62 1 37 43 2-s2.0-12944319290 10.1111/j.1365-2265.2004.02170.x (Pubitemid 40175281)
75. Mccance D. R., Dyer D. G., Dunn J. A., Bailie K. E., Thorpe S. R., Baynes J. W., Lyons T. J., Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. Journal of Clinical Investigation 1993 91 6 2470 2478 2-s2.0-0027233741 (Pubitemid 23182498)
76. Singh R., Barden A., Mori T., Beilin L., Advanced glycation end-products: a review. Diabetologia 2001 44 2 129 146 2-s2.0-0035135246 10.1007/ s001250051591 (Pubitemid 32156196)
77. Diamanti-Kandarakis E., Piouka A., Livadas S., Piperi C., Katsikis I., Papavassiliou A. G., Panidis D., Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome. European Journal of Endocrinology 2009 160 5 847 853 2-s2.0-65549168984 10.1530/EJE-08-0510
78. Chatterjee R., Bajoria R., New concept in natural history and management of diabetes mellitus in thalassemia major diabetes and thalassaemia. Hemoglobin 2009 33 supplement 1 S127 S130 2-s2.0-73949118610 10.3109/09553000903347880
79. Paolisso G., Tagliamonte M. R., Rizzo M. R., Giugliano D., Advancing age and insulin resistance: new facts about an ancient history. European Journal of Clinical Investigation 1999 29 9 758 769 2-s2.0-0032835938 10.1046/j.1365-2362. 1999.00522.x (Pubitemid 29425517)
80. Sattarahmady N., Heli H., Moosavi-Movahedi A. A., Desferal as improving agent for hemoglobin fructation: structural and functional impacts. The Protein Journal 2012 31 8 651 655 10.1007/s10930-012-9444-3
81. Fibach E., Rachmilewitz E. A., The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia. Annals of the New York Academy of Sciences 2010 1202 10 16 2-s2.0-77955905915 10.1111/j.1749-6632.2010.05577.x
82. Compagno L. M., Caring for adults with thalassemia in a pediatric world. Annals of the New York Academy of Sciences 2005 1054 266 272 2-s2.0-29744432606 10.1196/annals.1345.034 (Pubitemid 43031033)